BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21627493)

  • 1. Evaluation of a commercially available rapid urinary porphobilinogen test.
    Vogeser M; Stauch T
    Clin Chem Lab Med; 2011 Sep; 49(9):1491-4. PubMed ID: 21627493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid spectrophotometric quantification of urinary porphyrins and porphobilinogen as screening tool for attacks of acute porphyria.
    Lang A; Heckl C; Vogeser M; Stauch T; Homann C; Hennig G; Sroka R; Stepp H
    J Biomed Opt; 2018 May; 23(5):1-12. PubMed ID: 29855177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria.
    Marsden JT; Rees DC
    J Clin Pathol; 2014 Jan; 67(1):60-5. PubMed ID: 23908454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dark red urine].
    Füessl HS
    MMW Fortschr Med; 2014 Apr; 156(7):33. PubMed ID: 24956650
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute intermittent porphyria: a diagnostic challenge.
    Anyaegbu E; Goodman M; Ahn SY; Thangarajh M; Wong M; Shinawi M
    J Child Neurol; 2012 Jul; 27(7):917-21. PubMed ID: 22190498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remarks on the acute intermittent porphyria.
    Pfäfflin A
    Ann Clin Biochem; 2009 Jul; 46(Pt 4):347-8; author reply 348. PubMed ID: 19564164
    [No Abstract]   [Full Text] [Related]  

  • 7. Images in emergency medicine. Acute intermittent porphyria.
    Mumoli N; Vitale J; Cei M
    Ann Emerg Med; 2014 Feb; 63(2):267, 273. PubMed ID: 24438652
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute intermittent porphyria, seizures, and antiepileptic drugs: a report on a 3-year-old Nigerian boy.
    Sykes RM
    Seizure; 2001 Jan; 10(1):64-6. PubMed ID: 11181101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct and simultaneous determination of 5-aminolaevulinic acid and porphobilinogen in urine by hydrophilic interaction liquid chromatography-electrospray ionisation/tandem mass spectrometry.
    Benton CM; Couchman L; Marsden JT; Rees DC; Moniz C; Lim CK
    Biomed Chromatogr; 2012 Aug; 26(8):1033-40. PubMed ID: 22740490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A family with acute intermittent porphyria.
    Billoo AG; Lone SW
    J Coll Physicians Surg Pak; 2008 May; 18(5):316-8. PubMed ID: 18541093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular diagnostics of acute intermittent porphyria.
    Kauppinen R
    Expert Rev Mol Diagn; 2004 Mar; 4(2):243-9. PubMed ID: 14995910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of urinary porphobilinogen and porphyrins: preliminary data from a pilot QA scheme.
    Allen KR; Rushworth PA; Degg TJ; Barth JH
    Ann Clin Biochem; 1997 Sep; 34 ( Pt 5)():553-5. PubMed ID: 9293313
    [No Abstract]   [Full Text] [Related]  

  • 13. Mass spectrometric characterisation of a condensation product between porphobilinogen and indolyl-3-acryloylglycine in urine of patients with acute intermittent porphyria.
    Marcos J; Ibañez M; Ventura R; Segura J; To-Figueras J; Pozo OJ
    J Mass Spectrom; 2015 Jul; 50(7):929-37. PubMed ID: 26349648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anesthetic management of a patient with a history of acute intermittent porphyria and an elevation of urinary porphobilinogen].
    Hiraki T; Oishi K; Kano T
    Masui; 2001 Aug; 50(8):882-5. PubMed ID: 11554022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in the diagnosis and treatment of a case of acute intermittent porphyria in India.
    Dosi RV; Ambaliya AP; Patell RD; Sonune NN
    J Postgrad Med; 2013; 59(3):241-2. PubMed ID: 24029211
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of acute porphyria: evaluation of a commercial screening test for urinary porphobilinogen.
    Deacon AC; Peters TJ
    Ann Clin Biochem; 1998 Nov; 35 ( Pt 6)():726-32. PubMed ID: 9838985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.
    Sardh E; Harper P; Andersson DE; Floderus Y
    Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A YOUNG GIRL WITH FITS.
    Ahmed I; Ahmed E; Zaidi BH; Ansari JK; Nisar S
    J Ayub Med Coll Abbottabad; 2015; 27(1):232-3. PubMed ID: 26182784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yeast, creatinine and false diagnosis of porphyria.
    Schoenfeld N; Sztern M; Mamet R
    Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):81-8. PubMed ID: 9074792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CME: Acute Intermittent Porphyria: When to Think of It? What Must be Checked? How to Treat?].
    Senn JD; Huber LC; Barman-Aksözen J; Minder E
    Praxis (Bern 1994); 2018 Jan; 107(3):117-124. PubMed ID: 29382268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.